CN104807988B - 一种嗜碱性粒细胞的特异性免疫识别方法 - Google Patents
一种嗜碱性粒细胞的特异性免疫识别方法 Download PDFInfo
- Publication number
- CN104807988B CN104807988B CN201510214042.XA CN201510214042A CN104807988B CN 104807988 B CN104807988 B CN 104807988B CN 201510214042 A CN201510214042 A CN 201510214042A CN 104807988 B CN104807988 B CN 104807988B
- Authority
- CN
- China
- Prior art keywords
- basophilic granulocyte
- human
- recognition method
- streaming
- specific immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003714 granulocyte Anatomy 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 18
- 230000036039 immunity Effects 0.000 title abstract description 6
- 238000012360 testing method Methods 0.000 claims abstract description 26
- 210000004369 blood Anatomy 0.000 claims abstract description 16
- 102000006354 HLA-DR Antigens Human genes 0.000 claims abstract description 15
- 108010058597 HLA-DR Antigens Proteins 0.000 claims abstract description 15
- 239000008280 blood Substances 0.000 claims abstract description 13
- 238000011068 loading method Methods 0.000 claims abstract description 13
- 210000004027 cell Anatomy 0.000 claims abstract description 12
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 10
- 238000011534 incubation Methods 0.000 claims abstract description 7
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 16
- 238000002372 labelling Methods 0.000 claims description 12
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 6
- 238000001215 fluorescent labelling Methods 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000003139 buffering effect Effects 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 abstract description 3
- 239000011886 peripheral blood Substances 0.000 abstract description 3
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 abstract 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- 201000010099 disease Diseases 0.000 description 25
- 230000002052 anaphylactic effect Effects 0.000 description 15
- 208000003455 anaphylaxis Diseases 0.000 description 12
- 206010002198 Anaphylactic reaction Diseases 0.000 description 10
- 230000036783 anaphylactic response Effects 0.000 description 10
- 239000013566 allergen Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 210000003630 histaminocyte Anatomy 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 3
- 208000035474 group of disease Diseases 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 206010002216 Anaphylactoid reaction Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000222 eosinocyte Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003147 molecular marker Substances 0.000 description 2
- 206010004173 Basophilia Diseases 0.000 description 1
- 102000004499 CCR3 Receptors Human genes 0.000 description 1
- 108010017316 CCR3 Receptors Proteins 0.000 description 1
- 101150019010 CCR3 gene Proteins 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000001718 Immediate Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000010790 Interleukin-3 Receptors Human genes 0.000 description 1
- 108010038452 Interleukin-3 Receptors Proteins 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- 206010045240 Type I hypersensitivity Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 201000010659 intrinsic asthma Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510214042.XA CN104807988B (zh) | 2015-04-29 | 2015-04-29 | 一种嗜碱性粒细胞的特异性免疫识别方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510214042.XA CN104807988B (zh) | 2015-04-29 | 2015-04-29 | 一种嗜碱性粒细胞的特异性免疫识别方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104807988A CN104807988A (zh) | 2015-07-29 |
CN104807988B true CN104807988B (zh) | 2017-02-01 |
Family
ID=53692994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510214042.XA Active CN104807988B (zh) | 2015-04-29 | 2015-04-29 | 一种嗜碱性粒细胞的特异性免疫识别方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104807988B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111549091B (zh) * | 2020-05-21 | 2023-11-17 | 核工业总医院 | 一种嗜碱性粒细胞活化、脱颗粒的测试方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010043724A1 (en) * | 2008-10-17 | 2010-04-22 | Mead Johnson & Company | Method for identifying allergenic proteins and peptides |
CN102590492A (zh) * | 2012-02-22 | 2012-07-18 | 江苏苏中药业集团股份有限公司 | 一种生脉液体制剂类过敏反应的检测方法 |
-
2015
- 2015-04-29 CN CN201510214042.XA patent/CN104807988B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010043724A1 (en) * | 2008-10-17 | 2010-04-22 | Mead Johnson & Company | Method for identifying allergenic proteins and peptides |
CN102590492A (zh) * | 2012-02-22 | 2012-07-18 | 江苏苏中药业集团股份有限公司 | 一种生脉液体制剂类过敏反应的检测方法 |
Non-Patent Citations (4)
Title |
---|
Monitoring of Basophil Activation Using CD63 and CCR3 in Allergy to Muscle Relaxant Drugs;Guillaume Monneret et al.;《Clinical Immunology》;20020228;第102卷(第2期);摘要,193页右栏17-20行、194页左栏1-2段、195页右栏最后1段、196页右栏3-7行、197页右栏最后1段,图1 * |
嗜碱性粒细胞CD63分子表达变化在过敏性疾病诊断中的意义;张慧云等;《江苏医药》;20120930;第38卷(第18期);2181-2183 * |
外周血嗜碱粒细胞的定量研究;孙林等;《中国医药指南》;20110131;第9卷(第3期);摘要,49页左栏第1段、49-50页1.1-1.4节、讨论部分 * |
流式细胞术分析嗜碱性粒细胞活化试验在过敏性疾病诊断中的应用;张皓月等;《中国医药导报》;20140430;第11卷(第10期);164-168 * |
Also Published As
Publication number | Publication date |
---|---|
CN104807988A (zh) | 2015-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jung et al. | Immature platelet fraction: establishment of a reference interval and diagnostic measure for thrombocytopenia | |
CN104777303B (zh) | 一种嗜碱性粒细胞激活、脱颗粒的鉴定方法 | |
WO2021012925A1 (zh) | 一种人外周血淋巴细胞的检测方法 | |
CN107084916A (zh) | 一种循环肿瘤细胞分离微流控芯片装置及其使用方法 | |
CN106635995A (zh) | 一种循环肿瘤细胞阴性富集方法 | |
CN104677810A (zh) | 嗜碱性粒细胞活化的检测试剂盒及其使用方法 | |
CN103424555B (zh) | 一种输血前配合试验的试剂组及其试验方法 | |
CN103592432A (zh) | 一种免疫磁珠分离精子与上皮细胞混合斑中精子的方法 | |
CN109884313A (zh) | 急性b淋巴细胞白血病微小残留的检测试剂盒 | |
CN105223361A (zh) | 一种检测急性t淋巴细胞白血病幼稚t细胞的试剂盒、应用及方法 | |
CN203083997U (zh) | ABO、RhD血型抗原检测卡 | |
CN106989970A (zh) | 细胞分离制片染色一体装置和循环肿瘤细胞捕获方法 | |
CN104807988B (zh) | 一种嗜碱性粒细胞的特异性免疫识别方法 | |
CN206906211U (zh) | 一种循环肿瘤细胞分离微流控芯片装置 | |
CN106996976A (zh) | 基于微流控技术的ctc蛋白质分型试剂盒 | |
CN105403712A (zh) | 一种高性能的人尿液α1酸性糖蛋白检测试剂盒 | |
CN101864492A (zh) | 用于强直性脊柱炎辅助诊断的核酸检测试剂盒 | |
CN112098646B (zh) | 一种定量检测淋巴细胞亚群的试剂盒及其检测方法 | |
Binnicker et al. | Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2 | |
CN104792687B (zh) | 一种嗜碱性粒细胞致敏状态的鉴定方法 | |
CN109030322A (zh) | 一种节约成本的流式细胞术检测方法 | |
Zahedipour et al. | Development of flow cytometry-fluorescent in situ hybridization (Flow-FISH) method for detection of PML/RARa Chromosomal Translocation in acute promyelocytic leukemia cell line | |
CN108181470B (zh) | 一种检测黄疸血样中内毒素和(1-3)-β-D-葡聚糖含量的试剂盒及检测方法 | |
CN105132572A (zh) | 一种无创产前筛查21-三体综合征试剂盒 | |
WO2018170875A1 (zh) | 一种基因纳米锚定和微流体免疫凝集技术的宠物防诊方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160517 Address after: 121004, Fairview District, Taihe District, Jinzhou City, Liaoning Province, D, 35-97 Applicant after: He Shaoheng Address before: 121001 No. five, Section 2, Renmin Street, Guta District, Liaoning, Jinzhou Applicant before: No.1 Hospital Attached To Liaoning Medical College |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170630 Address after: 121010, 29, Yu Jie street, Taihe District, Liaoning, Jinzhou Patentee after: Liaoning universal source of biomedical science and Technology Development Co., Ltd. Address before: 121004, Fairview District, Taihe District, Jinzhou City, Liaoning Province, D, 35-97 Patentee before: He Shaoheng |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Specific immunity recognition method for basophilic granulocyte Effective date of registration: 20190808 Granted publication date: 20170201 Pledgee: Jinzhou Bank Co., Ltd. Shifulu Branch of Science and Technology Pledgor: Liaoning universal source of biomedical science and Technology Development Co., Ltd. Registration number: Y2019990000043 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200408 Granted publication date: 20170201 Pledgee: Jinzhou Bank Co., Ltd. Shifulu Branch of Science and Technology Pledgor: LIAONING HUIPUYUAN BIOMEDICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. Registration number: Y2019990000043 |